Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy | Synapse

March 22, 2021Open Access

Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy

AGAbdallah Sassine GearaUniversity of Pennsylvania VBVijay BhojHospital of the University of Pennsylvania JHJonathan J. HoganUniversity of Pennsylvania

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This case suggests that considering the source of PLA2R antibody production could lead to individualized and targeted therapies for MN.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Geara et al. (Mon,) studied this question.

synapsesocial.com/papers/69dbc89537b5141e3ba3d404 https://doi.org/https://doi.org/10.1159/000515087